Goldman Sachs Group Inc Eargo, Inc. Transaction History

Goldman Sachs Group Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 May 14, 2024	SELL	$0.49 - $0.73 $28,660 - $42,698	-58,491 Reduced 82.67%	12,259 $6,000
Q4 2022 Feb 13, 2023	BUY	$0.49 - $0.73 $6,006 - $8,949	12,259 New	12,259 $6,000
Q2 2022 May 14, 2024	BUY	$0.75 - $5.6 $53,062 - $396,200	70,750 New	70,750 $53,000
Q2 2022 Aug 15, 2022	SELL	$0.75 - $5.6 $205,696 - $1.54 Million	-274,262 Reduced 79.49%	70,750 $53,000
Q1 2022 May 16, 2022	BUY	$3.3 - $7.28 $789,756 - $1.74 Million	239,320 Added 226.43%	345,012 $1.83 Million
Q4 2021 Feb 14, 2022	BUY	$4.6 - $10.21 $130,552 - $289,770	28,381 Added 36.71%	105,692 $539,000
Q3 2021 Nov 10, 2021	BUY	$6.59 - $38.71 $509,479 - $2.99 Million	77,311 New	77,311 $520,000

33.4K

Ticker EAR
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 39,411,000
Market Cap $2.78B
Description
Eargo, Inc., a medical device company, engages in enhancing the quality of life of people with hearing loss in the United States. The company markets and sells hearing aids. It sells its products direct-to-consumer and through omni-channel. The company was formerly known as Aria Innovations, Inc. and changed its name to Eargo, Inc. in November 2...

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

Stay updated on Goldman Sachs Group Inc with notifications on news.